SOX17 and cholangiocarcinoma: Notably, in CCA tumor tissues, the promoter of SOX17—a negative regulator of the WNT–β-catenin pathway—was found to be hypermethylated when compared with adjacent healthy tissue, and this methylation status correlated with a poorer prognosis following tumor resection [49].